학술논문
85 - Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment
Document Type
Abstract
Author
Source
In Leukemia Research April 2017 55 Supplement 1:S54-S54
Subject
Language
ISSN
0145-2126